John J. Castellot

5.4k total citations
77 papers, 4.4k citations indexed

About

John J. Castellot is a scholar working on Molecular Biology, Cell Biology and Cancer Research. According to data from OpenAlex, John J. Castellot has authored 77 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Molecular Biology, 26 papers in Cell Biology and 21 papers in Cancer Research. Recurrent topics in John J. Castellot's work include Proteoglycans and glycosaminoglycans research (22 papers), Protease and Inhibitor Mechanisms (18 papers) and Connective Tissue Growth Factor Research (15 papers). John J. Castellot is often cited by papers focused on Proteoglycans and glycosaminoglycans research (22 papers), Protease and Inhibitor Mechanisms (18 papers) and Connective Tissue Growth Factor Research (15 papers). John J. Castellot collaborates with scholars based in United States, Italy and France. John J. Castellot's co-authors include Morris J. Karnovsky, Thomas C. Wright, Michael R. Miller, Arthur B. Pardee, Bruce M. Spiegelman, Robert Rosenberg, Benjamin Caleb, David L. Cochran, M J Karnovsky and Leonard Favreau and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

John J. Castellot

76 papers receiving 4.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John J. Castellot United States 36 2.3k 1.3k 746 610 572 77 4.4k
Eliza Vasile United States 30 2.1k 0.9× 1.0k 0.8× 495 0.7× 507 0.8× 896 1.6× 34 4.0k
Caroline Bonnans France 22 1.5k 0.7× 703 0.6× 615 0.8× 561 0.9× 657 1.1× 32 4.8k
John Hood United States 30 4.2k 1.8× 769 0.6× 938 1.3× 542 0.9× 314 0.5× 56 7.2k
Colin N. Chesterman Australia 33 1.7k 0.7× 387 0.3× 510 0.7× 274 0.4× 581 1.0× 67 4.1k
Åke Wasteson Sweden 40 4.5k 1.9× 2.2k 1.8× 934 1.3× 397 0.7× 610 1.1× 88 7.6k
Taro Hayakawa Japan 42 1.8k 0.8× 531 0.4× 2.4k 3.2× 343 0.6× 482 0.8× 140 5.7k
Eckhart Buddecke Germany 31 1.9k 0.8× 1.4k 1.1× 469 0.6× 309 0.5× 590 1.0× 206 3.8k
Anil K. Chauhan United States 41 1.7k 0.7× 623 0.5× 521 0.7× 306 0.5× 441 0.8× 129 5.3k
Toshihiko Terao Japan 43 1.6k 0.7× 637 0.5× 1.2k 1.6× 165 0.3× 404 0.7× 220 5.8k
Todd D. Camenisch United States 32 2.8k 1.2× 1.1k 0.9× 327 0.4× 532 0.9× 633 1.1× 58 5.5k

Countries citing papers authored by John J. Castellot

Since Specialization
Citations

This map shows the geographic impact of John J. Castellot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John J. Castellot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John J. Castellot more than expected).

Fields of papers citing papers by John J. Castellot

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John J. Castellot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John J. Castellot. The network helps show where John J. Castellot may publish in the future.

Co-authorship network of co-authors of John J. Castellot

This figure shows the co-authorship network connecting the top 25 collaborators of John J. Castellot. A scholar is included among the top collaborators of John J. Castellot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John J. Castellot. John J. Castellot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Grünberg, John, Jenny Hoffmann, Shahram Hedjazifar, et al.. (2017). Overexpressing the novel autocrine/endocrine adipokine WISP2 induces hyperplasia of the heart, white and brown adipose tissues and prevents insulin resistance. Scientific Reports. 7(1). 26 indexed citations
2.
Perbal, Bernard, Philip C. Trackman, John J. Castellot, et al.. (2014). Report on the 7th international workshop on the CCN family of genes. Journal of Cell Communication and Signaling. 8(1). 71–76. 2 indexed citations
3.
Wise, Steven G., et al.. (2013). Elastin biology and tissue engineering with adult cells. BioMolecular Concepts. 4(2). 173–185. 16 indexed citations
4.
Nowak, Romana A., et al.. (2003). Heparin Inhibits the Motility and Proliferation of Human Myometrial and Leiomyoma Smooth Muscle Cells. American Journal Of Pathology. 162(6). 1895–1904. 26 indexed citations
5.
Blondin, Catherine, et al.. (2003). Heparin inhibits lipopolysaccharide (LPS) binding to leukocytes and LPS‐induced cytokine production. Journal of Biomedical Materials Research Part A. 66A(2). 376–384. 22 indexed citations
6.
Delmolino, Laurie M., Nancy A. Stearns, & John J. Castellot. (2001). COP‐1, a member of the CCN family, is a heparin‐induced growth arrest specific gene in vascular smooth muscle cells. Journal of Cellular Physiology. 188(1). 45–55. 37 indexed citations
7.
Mishra-Gorur, Ketu, Laurie M. Delmolino, & John J. Castellot. (1998). Biological Functions of Heparan Sulfates.. Trends in Glycoscience and Glycotechnology. 10(52). 193–210. 8 indexed citations
8.
Delmolino, Laurie M. & John J. Castellot. (1997). Heparin suppressessgk, an early response gene in proliferating vascular smooth muscle cells. Journal of Cellular Physiology. 173(3). 371–379. 35 indexed citations
9.
Foxall, Carrol, Wei Zheng, Mary Schaefer, et al.. (1996). Sulfated malto-oligosaccharides bind to basic FGF, inhibit endothelial cell proliferation, and disrupt endothelial cell tube formation. Journal of Cellular Physiology. 168(3). 657–667. 14 indexed citations
10.
Caleb, Benjamin, Mitchell Hardenbrook, Van Cherington, & John J. Castellot. (1996). Isolation of vascular smooth muscle cell cultures with altered responsiveness to the antiproliferative effect of heparin. Journal of Cellular Physiology. 167(2). 185–195. 14 indexed citations
11.
Castellot, John J., et al.. (1991). Vascular graft intimal fibrous hyperplasia: Prospects for pharmacological inhibition. Journal of Vascular Surgery. 13(5). 758–761. 14 indexed citations
12.
Castellot, John J.. (1990). Heparan Sulfates: Physiologic Regulators of Smooth Muscle Cell Proliferation?. American Journal of Respiratory Cell and Molecular Biology. 2(1). 11–12. 11 indexed citations
13.
Pukac, Laurie, John J. Castellot, Thomas C. Wright, Benjamin Caleb, & Morris J. Karnovsky. (1990). Heparin inhibits c-fos and c-myc mRNA expression in vascular smooth muscle cells.. PubMed. 1(5). 435–443. 116 indexed citations
14.
Karnovsky, Morris J., Thomas C. Wright, John J. Castellot, et al.. (1989). Heparin, Heparan Sulfate, Smooth Muscle Cells, and Atherosclerosisa. Annals of the New York Academy of Sciences. 556(1). 268–281. 37 indexed citations
15.
Cochran, David L., John J. Castellot, John M. Robinson, & Morris J. Karnovsky. (1988). Heparin modulates the secretion of a major excreted protein-like molecule by vascular smooth muscle cells. Biochimica et Biophysica Acta (BBA) - General Subjects. 967(2). 289–295. 14 indexed citations
16.
Castellot, John J., Thomas C. Wright, & M J Karnovsky. (1987). Regulation of Vascular Smooth Muscle Cell Growth by Heparin and Heparan Sulfates. Seminars in Thrombosis and Hemostasis. 13(4). 489–503. 95 indexed citations
17.
Robinson, John M., Tomoko Okada, John J. Castellot, & Morris J. Karnovsky. (1986). Unusual lysosomes in aortic smooth muscle cells: presence in living and rapidly frozen cells.. The Journal of Cell Biology. 102(5). 1615–1622. 57 indexed citations
18.
Castellot, John J., David L. Cochran, & Morris J. Karnovsky. (1985). Effect of heparin on vascular smooth muscle cells. I. Cell metabolism. Journal of Cellular Physiology. 124(1). 21–28. 200 indexed citations
19.
Castellot, John J., Morris J. Karnovsky, & Bruce M. Spiegelman. (1980). Potent stimulation of vascular endothelial cell growth by differentiated 3T3 adipocytes.. Proceedings of the National Academy of Sciences. 77(10). 6007–6011. 63 indexed citations
20.
Shear, Leroy, et al.. (1966). ENHANCEMENT OF PERITONEAL FLUID ABSORPTION BY DEHYDRATION, MERCAPTOMERIN AND VASOPRESSIN. Journal of Pharmacology and Experimental Therapeutics. 154(2). 289–297. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eliza Vasile Breakdown of academic impact, for papers by Caroline Bonnans Breakdown of academic impact, for papers by John Hood Breakdown of academic impact, for papers by Colin N. Chesterman Breakdown of academic impact, for papers by Åke Wasteson Breakdown of academic impact, for papers by Taro Hayakawa Breakdown of academic impact, for papers by Eckhart Buddecke Breakdown of academic impact, for papers by Anil K. Chauhan Breakdown of academic impact, for papers by Toshihiko Terao Breakdown of academic impact, for papers by Todd D. Camenisch
Rankless by CCL
2026